Online magazine highlighting research, news and analysis covering the European Neighbourhood

Trump tariffs put India’s pharmaceuticals sector in the EU’s spotlight

U.S. Tariffs Propel EU-India Free Trade Agreement Talks Forward

In the wake of escalating U.S. tariffs, the European Union (EU) and India have intensified efforts to finalize a long-pending free trade agreement (FTA), aiming to conclude negotiations by the end of 2025. This renewed vigor in discussions underscores both parties’ desire to bolster economic ties and mitigate the impact of global trade uncertainties.

https://twitter.com/Indianinfoguide/status/1888919493906182435​

The EU and India initiated FTA negotiations in 2007, but talks stalled in 2013 due to disagreements over key issues such as market access, intellectual property rights, and labor mobility. After nearly a decade-long hiatus, negotiations resumed in 2022, with both sides expressing a commitment to reach a comprehensive agreement.​

The recent imposition of steep tariffs by the United States on various imports has disrupted global trade dynamics, prompting the EU and India to seek alternative partnerships. President Donald Trump’s administration announced tariffs as high as 145% on certain goods, affecting trade flows and prompting retaliatory measures from affected countries. This environment has accelerated the EU-India FTA talks, as both parties aim to secure economic stability through diversified trade relationships.

https://twitter.com/Normal_2610/status/1913550625151045975​

Key Areas of Negotiation

The FTA discussions encompass a broad range of sectors, with particular focus on the following topics:

  • Tariff Reductions: The EU seeks significant cuts in India’s high tariffs on automobiles, alcoholic beverages, and dairy products. Conversely, India aims for reduced duties on its textiles, pharmaceuticals, and agricultural exports to the EU.

  • Intellectual Property Rights (IPR): India advocates for a balanced IPR regime that safeguards innovation while ensuring access to affordable medicines.

  • Labor Mobility: India is pushing for easier movement of skilled professionals to the EU, addressing its concerns over restrictive visa regimes.

  • Sustainability and Environmental Standards: The EU emphasizes adherence to environmental norms, including its Carbon Border Adjustment Mechanism, which India views as potentially trade-restrictive.

Brussels Signal thereby highlights how “India has been a major supplier of active pharmaceutical ingredients and produces about 20 per cent of all generic drugs. With robust production capabilities and a willingness to offer greater market access, as seen from its latest discussions with US counterparts, India has been positioning itself an increasingly attractive international partner.

The Indian regulatory environment, particularly regarding the pharmaceutical sector, notoriously suffers from lengthy bureaucratic delays and inconsistent enforcement of international quality standards. This has complicated India’s ability to export high-quality drugs consistently. Moreover, shifting domestic policies, inconsistent application of Good Manufacturing Practices (GMPs), criticism over quality issues and reports of harmful drugs have added uncertainty to the export process.”

Challenges Ahead

Despite mutual interest, several hurdles persist:

  • Political Transitions: Upcoming elections in key EU member states, such as Germany and Romania, may delay decision-making processes, potentially affecting the negotiation timeline.

  • Regulatory Divergences: Differences in regulatory frameworks, particularly concerning data protection and environmental standards, require careful alignment to prevent future trade disputes.

  • Trust Deficit: Past negotiation breakdowns have led to a trust deficit, necessitating confidence-building measures to ensure sustained engagement.

Strategic Importance

For the EU, finalizing the FTA with India aligns with its strategy to diversify trade partnerships and reduce reliance on traditional allies amid shifting geopolitical landscapes. India, on the other hand, views the agreement as a means to integrate more deeply into global value chains, attract foreign investment, and boost its manufacturing sector. 

The EU-India FTA negotiations, reinvigorated by the current global trade climate, represent a significant opportunity for both parties to enhance economic cooperation. While challenges remain, the shared commitment to concluding the agreement by the end of 2025 reflects a strategic alignment aimed at fostering mutual growth and resilience in an increasingly uncertain world.